Ignite Creation Date:
2024-07-17 @ 10:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06467383
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-21
First Post:
2024-06-14
Brief Title:
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
Sponsor:
MSD Italia Srl
Organization:
MSD Italia Srl
Study Overview
Official Title:
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Key-Early
Brief Summary:
This is a non-interventional retrospective observational study to improve knowledge regarding the diagnosis and treatments of patients who havehad non-small cell lung cancer NSCLC either early stage stage I-II
Detailed Description:
Due to heterogeneity of patients with stage I-III Non Small Cell Lung Cancer NSCLC there is not a unique common therapeutic approach and there is no consensus about the optimal timing sequencing and combination of surgery chemotherapy and radiotherapy across the spectrum of early stage and locally advance disease Consequently the choice of local treatment modality can vary across countries and centers
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None